StoneX Group’s Fresenius Medical Care FMS Stock Holding History

StoneX Group’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,055	Closed	-$294K	–	579
2021 Q4	$294K	Buy	+9,055	New	+$298K	0.03%	413

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

StoneX Group's FMS Position: Q1 2022 in Review

StoneX Group sold out of Fresenius Medical Care (FMS) in Q1 2022, closing a stake of 9,055 shares — an estimated $294K sold.

StoneX Group first reported a position in FMS in Q4 2021 and held it in 1 quarter. The position peaked at $294K in Q4 2021. 178 funds tracked by Wall St. Rank hold FMS as of Q1 2022.

StoneX Group reported no remaining Fresenius Medical Care position as of Q1 2022 after selling out during the quarter.
StoneX Group sold 9,055 Fresenius Medical Care shares in Q1 2022, an estimated $294K.
StoneX Group first reported a position in Fresenius Medical Care in Q4 2021 and held it in 1 quarter.
StoneX Group's Fresenius Medical Care position peaked at $294K in Q4 2021.
178 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2022.

Based on StoneX Group's 13F filing for Q1 2022, filed 11 May 2022.